A Phase 1 study on single oral dose administration of ONO-2160/CD in healthy adult male subjects and Parkinson's disease patients
Latest Information Update: 07 Jun 2016
At a glance
- Drugs Carbidopa/ONO 2160 (Primary) ; Levodopa/carbidopa; ONO 2160
- Indications Parkinson's disease
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Ono Pharmaceutical
- 07 Jun 2016 New trial record